Tregs are one of the major cells capable of inducing dysfunction in DCs through the expression of high-affinity CD80 and CD86 ligands, cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4), which competes with CD28 on T cells and limits tumor immunogenesis [69]. This evidence concerns the gene CTLA4 and neoplasm.